WOCKPHARMANSEWockhardt Limited· PharmaceuticalsMediumNeutral
Announced Wed, 31 Dec · 18:22 IST

Wockhardt Limited has informed the Exchange that SES ESG Research Pvt Ltd, a SEBI registered ESG rating provider, has voluntarily assigned an ESG rating of 67.3 for the Financial Year 2024-25

WOCKPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Wockhardt Limited has disclosed that SES ESG Research Pvt Ltd, a SEBI-registered ESG rating provider, has voluntarily assigned it an ESG score of 67.3 for Financial Year 2024-25. Importantly, the company clarifies that it did not engage SES ESG Research for this rating — the score was independently determined by the provider based on Wockhardt's public disclosures and other publicly available information. The intimation has been made under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The filing is dated December 31, 2025, and is for informational and record purposes only.

Likely market impact

A score of 67.3 reflects a reasonably strong ESG standing for Wockhardt and may appeal to ESG-focused institutional investors. Because the rating was independently assigned and not commissioned, it carries more credibility, but the disclosure itself is largely informational and unlikely to trigger immediate share price movement.